BUY Shadowfax Technologies Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)8 Oct 2026via LiveMint Markets
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Shadowfax Technologies shares jump 137% from IPO price; ICICI Securities sees 15% upside | Should you buy?
NewsLivemint·8 Oct · yesterday
Logistics stock, already up 127% from IPO price, can see further upside, Kotak says
NewsCnbc-Tv18·23 Sept · 2w ago
Shadowfax Technologies Share Price In Focus After Kotak Equities Assigns 'Add' Rating, Sees 10% Upside
NewsNdtv-Profit·23 Sept · 2w ago
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·23 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Shadowfax Technologies
- BUY — Rakesh Bansal23 Sept 2026 · ~2 weeks · target ₹301 · SL hit
- BUY — Kotak Securities23 Sept 2026 · ~1 year · target ₹300 · Target hit
- BUY — Kotak Securities23 Sept 2026 · ~1 year · target ₹310 · Active
- BUY — Ashish Chaturmohta, JM Financial3 Sept 2026 · ~1 year · target ₹300 · SL hit
- BUY — Pankaj Randad19 Aug 2026 · ~2 weeks · target ₹290 · Expired
More from ICICI Securities
- BUY Eternal7 Oct 2026 · ~1 year · target ₹425 · Active
- BUY Gland Pharma5 Oct 2026 · ~1 year · target ₹3,430 · Active
- BUY SYMBIOTEC PHARMALAB1 Oct 2026 · ~1 year · target ₹1,540 · Active
- BUY Savita Oil Technologies30 Sept 2026 · ~1 year · target ₹950 · Active
- BUY Cyient DLM30 Sept 2026 · ~1 year · target ₹1,100 · Active

